Research output: Contribution to journal › Article › peer-review
Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. / Kondakova, Ekaterina A.; Golosova, Natalia N.; Kravchuk, Bogdana I. et al.
In: International Journal of Molecular Sciences, Vol. 27, No. 12, 5466, 17.06.2026.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae
AU - Kondakova, Ekaterina A.
AU - Golosova, Natalia N.
AU - Kravchuk, Bogdana I.
AU - Khlusevich, Yana A.
AU - Yakubovskij, Vyacheslav I.
AU - Kozlova, Yuliya N.
AU - Grishkova, Svetlana A.
AU - Tikunova, Nina V.
AU - Matveev, Andrey L.
N1 - Kondakova, E.A.; Golosova, N.N.; Kravchuk, B.I.; Khlusevich, Y.A.; Yakubovskij, V.I.; Kozlova, Y.N.; Grishkova, S.A.; Tikunova, N.V.; Matveev, A.L. Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. Int. J. Mol. Sci. 2026, 27, 5466. https://doi.org/10.3390/ijms27125466 This research was funded by the Russian Science Foundation, grant number 23-74-10105, https://rscf.ru/project/23-74-10105/ (access date 21 January 2026). The work on the cultivation of bacterial strains and the establishment of the in vivo model was supported by the Ministry of Education and Science, Project No. 125041005114-8.
PY - 2026/6/17
Y1 - 2026/6/17
N2 - Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the Escherichia coli expression system and purified. The depolymerase DepKP144 protein was able to reduce viable bacterial counts following capsule degradation in 95% of the tested strains of type K1 and 85% of the tested strains of type K2 Klebsiella pneumoniae. The depolymerase DepKP144 was active against K. pneumoniae K1-type and K2-type planktonic cells and destroyed the biofilms formed by clinical MDR strains of K. pneumoniae. In in vivo experiments, DepKP144 at a dose of 180 μg/mouse resulted in a 50% survival of the mice infected with K2-type K. pneumoniae and in a 17% survival of the mice infected with K1-type K. pneumoniae. This depolymerase is promising for further development of prevention and therapeutic candidates against MDR K. pneumoniae.
AB - Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the Escherichia coli expression system and purified. The depolymerase DepKP144 protein was able to reduce viable bacterial counts following capsule degradation in 95% of the tested strains of type K1 and 85% of the tested strains of type K2 Klebsiella pneumoniae. The depolymerase DepKP144 was active against K. pneumoniae K1-type and K2-type planktonic cells and destroyed the biofilms formed by clinical MDR strains of K. pneumoniae. In in vivo experiments, DepKP144 at a dose of 180 μg/mouse resulted in a 50% survival of the mice infected with K2-type K. pneumoniae and in a 17% survival of the mice infected with K1-type K. pneumoniae. This depolymerase is promising for further development of prevention and therapeutic candidates against MDR K. pneumoniae.
KW - K. pneumoniae
KW - K1-type
KW - K2-type
KW - Klebsiella pneumoniae
KW - antibacterials
KW - biofilm degradation
KW - capsular polysaccharide
KW - depolymerase
KW - multi drug resistance
KW - Klebsiella pneumoniae
KW - деполимераза
KW - множественная лекарственная устойчивость
KW - антибактериальные средства
KW - тип K1
KW - тип K2
KW - капсульный полисахарид
KW - разрушение биопленок
KW - K. pneumoniae
UR - https://www.mendeley.com/catalogue/8c952cc4-c68f-3d6b-ad3e-1e07fa1dac34/
UR - https://www.scopus.com/pages/publications/105042948030
U2 - 10.3390/ijms27125466
DO - 10.3390/ijms27125466
M3 - Article
C2 - 42353184
VL - 27
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1661-6596
IS - 12
M1 - 5466
ER -
ID: 85412706